Physician profile
Kyle Trauth
NPI 1922268911
$698.29
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $223 · 2020: $117 · 2022: $157 · 2023: $114 · 2024: $88.43.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $202.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $202.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $142.82 | 2019-2023 | Xifaxan, Trulance |
| Novo Nordisk INC | $87.18 | 2019-2024 | Wegovy |
| Abbvie INC. | $74.88 | 2022-2023 | Ubrelvy |
| Allergan, INC. | $65.92 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $56.93 | 2022-2024 | |
| Glaxosmithkline, LLC. | $54.23 | 2019-2023 | Shingrix, Trelegy Ellipta, Arexvy |
| Amgen INC. | $46.71 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $40.20 | 2024 | |
| Pfizer INC. | $33.43 | 2022-2023 | |
| Abbott Laboratories | $31.86 | 2022 | |
| Hologic Sales and Service, LLC | $15.67 | 2024 | Aptima, Thinprep 2000 Processor |
| Kowa Pharmaceuticals America, INC. | $13.51 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $13.32 | 2019 | |
| Janssen Pharmaceuticals, INC | $10.96 | 2019 | |
| Sumitomo Pharma America, INC. | $10.67 | 2023 | Gemtesa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Trauth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.